Publications

Contemporary activity of meropenem and comparator broad-spectrum agents: MYSTIC Program report from the Unite States component (2005). by Rhomberg PR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2007; 57 (2): 207-215

Multicenter studies of tigecycline disk diffusions susceptibility results for Acinetobacter spp. by Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM and Sader HS published in J. Clin. Microbiol. 2007; 45 (1): 227-230

Contemporary causes of skin and soft tissue infections in North America, Latin America and Europe: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 7-13

Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004). by Jones RN, Sader HS, Fritsche TR and Pottumarthy S published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 109-116

Serial sinus aspirate samples during high-dose, short course levofloxacin treatment of acute maxillary sinusitis. by Anon JB, Paglia M, Xiang J, Ambrose PG, Jones RN and Kahn JB published in Diagn. Microbiol. Infect. Dis. 2007; 57 (1): 105-107

In Vitro Activity of a Novel Carbapenem, Doripenem, Tested Against Bacterial Pathogens Recovered from Patients Hospitalized with Pneumonia (North America; 2003-2005), Lead author: Fritsche TR, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Antimicrobial Activity of Broad-Spectrum &#223-Lactams, Including Doripenem, Tested Against Bloodstream Infection Isolates: A Global Surveillance Report (2003-2005), Lead author: Fritsche TR, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Evaluation of Daptomycin Activity Tested against 34,603 Bacterial Strains from Hospitalized Patients: Summary of a 4 Year Surveillance Program for North America and Europe (2002-2005), Lead author: Jones RN, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Activity of Daptomycin and Selected Antimicrobial Agents against Staphylococcus aureus Isolated from Patients with Bacteremia in North America: A Four Year Analysis, Lead author: Sader HS, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Re-Evaluation of the Cefdinir Activity Tested Against Contemporary Isolates from Skin and Soft Tissue Infections (SSTI; 2005), Lead author: Sader HS, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Comparison of Cefepime and Ceftriaxone Bactericidal Activity Against Streptococcus pneumoniae, Lead author: Sader HS, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Comparative Activity of Broad-Spectrum Antimicrobial Agents Used in the Treatment of Serious Infections Caused by Non-Enteric Gram Negative Bacilli: Seventh Year Report from the MYSTIC Program (USA; 1999-2005), Lead author: Jones RN, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Antimicrobial Activity of Tigecycline and Other Broad-Spectrum Agents Tested Against Bloodstream Infection Isolates Collected Worldwide, Lead author: Sader HS, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

In Vitro Activity of Tigecycline Tested Against Pneumonia Pathogens from Hospitalized Patients: Results from a Global Surveillance Program (2004-2005), Lead author: Fritsche TR, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Pneumococcal Conjugate Vaccine (PCV7) Effect on Antibiograms: Serotype and Susceptibility (S) Rate Changes in the SENTRY Antimicrobial Surveillance Program (USA), Lead author: Jones RN, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes, Lead author: Mera RM, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Carbapenem Resistances Among P. aeruginosa Isolated in an USA Medical Center: Report of Osteomyelitis Caused by an IMP-15 Producing Strain, Lead author: Jones RN, presented at 44th annual Infectious Diseases Society of America (IDSA), October 12 – 15, 2006, Toronto, Ontario, Canada

Molecular Characterization of Rarely Isolated Garenoxacin-Resistant Streptococcus pneumoniae collected from the SENTRY Antimicrobial Surveillance Program (1999-2005), Lead author: Biedenbach DJ, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

hVISAs are Common Among Vancomycin Susceptible Methicillin-Resistant Staphylococcus aureus (MRSA); Report from SENTRY Asia-Pacific Region, Lead author: Bell JM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Eight-Year Trends in Carbapenem Resistance Rates in the MYSTIC Programme (USA; 1999-2006), Lead author: Rhomberg PR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Geographic Variations in the Activity of Doripenem and Other Broad-Spectrum Agents: Results from an International Surveillance Program (2003-2005), Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

A Multi-Site Comparison Study of the Sensititre Automated/Manual Susceptibility Plate to the CLSI Microdilution Method for Streptococcus spp. vs. Daptomycin, Lead author: Miskov AM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Re-Evaluation of Clinical and Laboratory Standards Institute (CLSI) Disk Diffusion Breakpoints for Tetracycline and Doxycycline When Testing Enterobacteriaceae, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Recommended Ulifloxacin MIC Quality Control Ranges Using a CLSI Multi-Laboratory M23-A2 Study Design, Lead author: Biedenbach DJ, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

An Assessment of the Sensititre Automated/Manual Susceptibility Plate in Detection of Vancomycin Non-Susceptible Staphylococcus spp., Lead author: Killian SB, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Vancomycin Hetero-resistance has a Small but Significant Effect on the Daptomycin Minimum Inhibitory Concentration of Staphylococcus aureus, Lead author: Bell JM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Spectrum and Potency of Ceftobiprole Tested Against Staphylococci and Streptococci Recovered from Patients in Latin America (2003-2005), Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Ceftobiprole Tested Against a Recent Collection of North American Pseudomonas aeruginosa, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Evaluation of the Bactericidal Activity of the Novel Cephalosporin Ceftaroline (PPI-0903M) Compared to Ceftriaxone against Streptococcus pneumoniae, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Activity of Doripenem Tested Against an International Collection of ESBL- and AmpC-Producing Enterobacteriaceae, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activities of Doripenem and Other Carbapenems Tested Against Pseudomonas aeruginosa, Other Non-Fermentative Bacilli and Aeromonas spp., Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Daptomycin in Combination with Gentamicin against Contemporary Clinical Isolates of Staphylococcus aureus and Enterococci, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In vitro Activity of Dalbavancin Susceptibility Tested Against Staphylococcus spp. and &#223-haemolytic Streptococcus spp. isolated in USA Medical Centers, Lead author: Biedenbach DJ, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Activity of Tigecycline (TIG) Tested Against Recent Acinetobacter spp. Isolates in North American (NA) Hospitals, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Activity of Tigecycline Tested against Vancomycin-Resistant Enterococcus faecium Isolated in North America (NA) and Europe (EU), Including Clonal Complex-17 (CC-17) Strains, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Evaluation of Colistin Alone or in Combination with Antimicrobial Agents Against Clinical Isolates of Carbapenem-Resistant P. aeruginosa (CR-PSA), Lead author: Chin JN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Longitudinal Evaluation of Linezolid Activity: Results from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Surveillance Program (2002-2005), Lead author: Ross JE, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Omiganan Pentahydrochloride Tested Against Vancomycin (VAN) Tolerant, Intermediate (VISA and hVISA) and Resistant (VRSA) S. aureus, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In vitro Activity of a 2′-Substituted-6-alkylidenepenicillin Sulfone (LN-1-255) as a &#223-Lactamase Inhibitor, Lead author: Buynak JD, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Spectrum and Activity of 2′-Substituted-6-alkylidenepenicillin Sulfone/&#223-lactam Combinations Screened Against Resistant Gram-Negative Bacilli, Lead author: Buynak JD, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Potency and Spectrum of DC-159a Tested Against More Than 800 Recent Clinical Isolates, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

DC-159a, a Novel Oral Quinolone, Activity Tested Against Community-Acquired Respiratory Tract (CA-RTI) Pathogens, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Comparative In Vitro Activity of DC-159a, a New Oral Fluoroquinolone, Against Viridans Streptococci, Lead author: Smith K, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of Nine Developmental Cationic Steroid Compounds (Ceragenins) Against Clinical Isolates of Clostridium difficile, Lead author: Fritsche TR, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

In Vitro Activity of DX-619 Compared to Other Agents against Viridans Streptococci, Lead author: Smith K, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Pneumococcal Conjugate Vaccine Effect on S. pneumoniae Serotype Carriage and Multidrug-Resistance in the United States, Lead author: Mera RM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activity of Tigecycline (TIG) Tested Against Serine Carbapenemase-Producing Enterobacteriaceae Isolated in the United States, Lead author: Sader HS, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular and Epidemiologic Characterization of Community-Associated Methicillin-Resistant S. aureus (CA-MRSA) Isolated from North American Medical Centers: Report from The SENTRY Program (2000- 2004), Lead author: Deshpande LM, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Molecular Characterization of S. aureus (SA) Isolates from a Contemporary (2005) Clinical Trial of Uncomplicated Skin and Skin Structure Infections (uSSSI), Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California

Antimicrobial Activity of Tigecycline against Community-Acquired Methicillin-Resistant S. aureus (CA-MRSA) Isolated in North American Medical Centers, Lead author: Jones RN, presented at 46th annual Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC), September 27 – 30, 2006, San Francisco, California